CorMedix (CRMD)
(Real Time Quote from BATS)
$6.29 USD
+0.22 (3.62%)
Updated Aug 30, 2024 02:06 PM ET
2-Buy of 5 2
F Value F Growth C Momentum F VGM
Brokerage Reports
CorMedix Inc [CRMD]
Reports for Purchase
Showing records 81 - 100 ( 101 total )
Company: CorMedix Inc
Industry: Medical - Biomedical and Genetics
We are suspending coverage in order to focus on other areas of interest to our institutional clients
Provider: STONEGATE CAPITAL MARKETS
Analyst: TRANG D
Company: CorMedix Inc
Industry: Medical - Biomedical and Genetics
Research Update: CRMD: Looking at strategic options and fighting IP battles
Provider: STONEGATE CAPITAL MARKETS
Analyst: TRANG D
Company: CorMedix Inc
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: CorMedix Inc
Industry: Medical - Biomedical and Genetics
1Q15 Recap - Progress, But No Conclusion on Litigation
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: CorMedix Inc
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: CorMedix Inc
Industry: Medical - Biomedical and Genetics
Waiting for Strategic Process to Play Out - Upping PT; Lowering Rating
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: CorMedix Inc
Industry: Medical - Biomedical and Genetics
Research Update: QIDP Label and Fast Track Status lead the way for possible strategic options
Provider: STONEGATE CAPITAL MARKETS
Analyst: TRANG D
Company: CorMedix Inc
Industry: Medical - Biomedical and Genetics
MID-DAY SUMMARY
Provider: Roth Capital Partners, Inc.
Company: CorMedix Inc
Industry: Medical - Biomedical and Genetics
Middle East Agreement Reinforces Neutrolin Forecasts
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: CorMedix Inc
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: CorMedix Inc
Industry: Medical - Biomedical and Genetics
Company: CorMedix Inc
Industry: Medical - Biomedical and Genetics
Company: CorMedix Inc
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: CorMedix Inc
Industry: Medical - Biomedical and Genetics
Company: CorMedix Inc
Industry: Medical - Biomedical and Genetics
Company: CorMedix Inc
Industry: Medical - Biomedical and Genetics
MID-DAY SUMMARY
Provider: Roth Capital Partners, Inc.
Company: CorMedix Inc
Industry: Medical - Biomedical and Genetics
We launch coverage with a Buy rating and $3/share price target.
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: CorMedix Inc
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: CorMedix Inc
Industry: Medical - Biomedical and Genetics
Initiation of Coverage: CRMD: Getting to the Core of Catheter Infections
Provider: STONEGATE CAPITAL MARKETS
Analyst: TRANG D
Company: CorMedix Inc
Industry: Medical - Biomedical and Genetics
Reallocating research resources-suspending coverage
Provider: GRIFFIN SECURITIES, INC.
Analyst: BEDRIJ C